Type 1 diabetes mellitus with diabetic amyotrophy
ICD-10 E10.44 is a billable code used to indicate a diagnosis of type 1 diabetes mellitus with diabetic amyotrophy.
Type 1 diabetes mellitus with diabetic amyotrophy is a specific complication of diabetes characterized by muscle weakness and atrophy, primarily affecting the proximal muscles of the lower limbs. This condition arises due to nerve damage caused by prolonged hyperglycemia, leading to neuropathy. Patients may experience symptoms such as pain, weakness, and difficulty in walking. The onset of diabetic amyotrophy is often gradual and can significantly impact the quality of life. Management of this condition involves strict glycemic control, often monitored through HbA1c levels, which should ideally be maintained below 7% to prevent further complications. Insulin therapy is typically required for Type 1 diabetes, and adjustments may be necessary to manage blood glucose levels effectively. Early recognition and intervention are crucial to mitigate the progression of diabetic amyotrophy and improve patient outcomes.
Detailed records of blood glucose levels, HbA1c results, and insulin management.
Patients presenting with uncontrolled diabetes and neurological symptoms.
Ensure comprehensive documentation of diabetes management plans and complications.
Thorough neurological assessments and documentation of muscle strength and function.
Patients with muscle weakness and pain in the context of diabetes.
Document the relationship between diabetes control and neurological symptoms.
Used for follow-up visits for diabetes management and complications.
Document the patient's diabetes management, HbA1c levels, and any complications.
Endocrinologists should ensure comprehensive diabetes management documentation.
Diabetic amyotrophy is a complication of diabetes characterized by muscle weakness and atrophy, primarily affecting the proximal muscles of the lower limbs due to nerve damage from prolonged high blood sugar levels.
E10.44 specifically denotes Type 1 diabetes with diabetic amyotrophy, requiring detailed documentation of neurological symptoms and their impact on the patient's functional status, unlike more general diabetes codes.
